Lidocaine HCl Injection USP
Recall D-0554-2026, part of FDA recall event 98976. See Spectra Medical Devices's company page.
Spectra Medical Devices, Llc started this Class II drug recall on May 12, 2026 (voluntary: firm initiated); FDA lists it as ongoing.
- Classification: Class II
- Started: May 12, 2026
- Status: Ongoing
Lack of Assurance of Sterility
- Product
- Lidocaine HCl Injection USP, 25x5 mL, Single-Dose Ampules, Rx Only, Distributed by: Spectra Medical Devices, LLC, Wilmington, Made in S. Korea, NDC 65282-1605-1.
- Quantity
- 210625 ampules
- Lots and codes
- Lot#: AE4013, Exp 1/31/2027; AE5032 & AE5039, Exp 3/31/2028; AE5104, Exp 8/31/2028.
- Distribution
- USA Nationwide
- Recalling firm
- Spectra Medical Devices, Llc, Wilmington, MA, United States
- How the firm notified
- Letter
- FDA classified
- Jun 2, 2026
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports